Guido De Wert

Datos Biográficos

ID1246474
NOMBREGuido De Wert
NOMBRESGuido
APELLIDODe Wert
FIRMADE WERT G
AFILIACIONESMaastricht University
ORCID0000-0002-0410-4902
VERIFICADOSí
TOTAL DE OBRAS9
TOTAL DE CITAS7
TOTAL COMO AUTOR9
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2007
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H2

  • Autonomy and prevention

    Open AccessWybo Dondorp, Guido De Wert et al.ARTICLEBioethics2025

    From an ethical point of view, there is an important distinction between two types of prenatal screening. The first of these targets maternal or foetal conditions (e.g., infectious diseases, blood group sensitization) where early detection allows for interventions that improve the chances of a healthy pregnancy outcome. The second screens for foetal conditions such as Down syndrome, where a timely diagnosis in most cases only allows for a choice …

  • Potentiality switches and epistemic uncertainty

    Open AccessAna M Pereira Daoud, Wybo Dondorp et al.ARTICLEMedicine Health Care and Philosophy2024

    Recent advancements in developmental biology enable the creation of embryo-like structures from human stem cells, which we refer to as human embryo-like structures (hELS). These structures provide promising tools to complement—and perhaps ultimately replace—the use of human embryos in clinical and fundamental research. But what if these hELS—when further improved—also have a claim to moral status? What would that imply for their research use? In …

  • Invisible work, actors, and knowledge

    Open AccessAnna Wolters, Guido De Wert et al.ARTICLEBioSocieties2020

  • Refining the ethics of preimplantation genetic diagnosis

    Open AccessWybo Dondorp, Guido De WertARTICLEBioethics2018

    Many European countries uphold a 'high risk of a serious condition' requirement for limiting the scope of preimplantation genetic diagnosis (PGD). This 'front door' rule should be loosened to account for forms of PGD with a divergent proportionality. This applies to both 'added PGD' (aPGD), as an add-on to in vitro fertilization (IVF), and 'combination PGD' (cPGD), for a secondary disorder in addition to the one for which the applicants have an a…

  • Dealing with treatment and transfer requests

    Open AccessMelisa Soto-Lafontaine, Wybo Dondorp et al.ARTICLEMedicine Health Care and Philosophy2017Citada por: 1Referencias: 4

    How do professionals working in pre-implantation genetic diagnosis (PGD) reflect upon their decision making with regard to ethical challenges arising in everyday practice? Two focus group discussions were held with staff of reproductive genetic clinics: one in Utrecht (The Netherlands) with PGD-professionals from Dutch PGD-centres and one in Prague (Czech Republic) with PGD-professionals working in centres in different European countries. Both me…

  • International clinical trials, cardiovascular disease and treatment options in the Russian Federation

    Open AccessOlga Zvonareva, Nora Engel et al.ARTICLESocial Science & Medicine2015Referencias: 28

  • Early prevention of antisocial behavior (ASB)

    Open AccessDorothee Horstkötter, Ron Berghmans et al.ARTICLEBioSocieties2014

  • Constructing a trial as a personal lifestyle change project

    Open AccessAnna Wolters, Guido De Wert et al.ARTICLESocial Science & Medicine2014Citada por: 3Referencias: 24

  • Flopping, Klapping and Gene Doping

    Open AccessIvo Van Hilvoorde, I M Van Hilvoorde et al.ARTICLESocial Studies of Science2007Citada por: 3Referencias: 3

    The application of genetic technology seems to threaten what is considered natural in elite sport. This paper explores the role of genetic technology in elite sport and questions the significance of dichotomizing between the natural and artificial element. How do shifts in technology affect the attribution of the human element in athletic performance? To explore the attribution of human agency we compare the genetic enhancement of athletes with t…